Surescripts Can't Limit Discovery In FTC Case
By Bryan Koenig ( February 27, 2020, 10:59 PM EST) -- Potential overlap with consolidated proposed class actions wasn't enough for a D.C. federal judge on Thursday to limit discovery in the Federal Trade Commission's case accusing Surescripts of using contract terms and other tactics to illegally maintain its monopoly over electronic prescription services....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.